SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Thyrocare Technologies informs about change in management

05 Jan 2026 Evaluate
Thyrocare Technologies has informed that the Board of Directors (Board) of Thyrocare Technologies (the Company), upon the recommendation of the Nomination and Remuneration Committee (NRC), has approved the appointment of Rajdeep Panwar as Chief Commercial Officer of the Company, categorised as Senior Management Personnel, with effect from January 05, 2026. The aforesaid appointment was approved by the Board by way of a resolution passed by circulation on January 05, 2026 at 11:07 AM (IST). In compliance with Regulation 30 of the SEBI LODR Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, the requisite disclosure is enclosed as Annexure - 1. The aforesaid disclosures are also being made available on the website of the Company at https://investor.thyrocare.com/announcements/.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

387.85 -4.75 (-1.21%)
21-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×